DRP-104 in Patients With NFE2L2/KEAP1-altered Non-Small Cell Lung Cancer
Clinical trial NCT07249372 · RECRUITING
Trial details
- NCT number
- NCT07249372
- Sponsor
- NYU Langone Health
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-14
- Primary completion
- 2027-10-31
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.